Delivery Order SPE2DR25D3103-SPE2DR26F9F81
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on April 21, 2025, for the supply of Opzelura 1.5% cream in 60-gram quantities, with a contract ceiling value of $1,310.45. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of April 22, 2025....
- AmerisourceBergen Drug Corp received a competitively awarded delivery order from the Defense Logistics Agency (DLA) on November 3, 2025, valued at $4,496.87 for the supply of Opzelura 1.5% cream (60 grams). The contract is a firm fixed-price delivery order with an ultimate completion date of November 4, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This award represents a non-set-aside procurement, indicating the opportunity was open to...
- The Defense Logistics Agency awarded a delivery order valued at $1,807.26 to AmerisourceBergen Drug Corp for the supply of Opzelura 1.5% Cream in 60-gram units. This firm fixed-price contract, issued on October 31, 2025, with completion by November 3, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The award was made through open...
- The Defense Logistics Agency awarded a $7,999.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 grams of Opzelura 1.5% cream, with an ultimate completion date of November 17, 2025. This non-competitive, non-set-aside award represents a child delivery order under AmerisourceBergen's substantial indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for Opzelura 1.5% Cream in a 60-gram quantity, valued at $7,600.66. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded transaction. The order is scheduled for ultimate completion on November 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $5,076.23 to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Opzelura 1.5% Cream in a 60-gram formulation. This firm fixed-price delivery order, which is not set-aside designated, is scheduled for completion by October 27, 2025, with performance taking place at the contractor's Conshohocken, Pennsylvania headquarters. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $7,733.24 to AmerisourceBergen Drug Corp for Opzelura 1.5% Cream (60GM) on November 7, 2025, with an ultimate completion date of November 10, 2025. This firm fixed-price contract represents a non-set-aside competitive award to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $76,019.41 to AmerisourceBergen Drug Corp for Opzelura 1.5% cream (60gm) on October 22, 2025, with an ultimate completion date of October 23, 2025. This firm fixed price, non-competitive delivery order represents a specific pharmaceutical requisition fulfilled through AmerisourceBergen's existing contract vehicle with DLA. The company, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $2,277.56 to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Opzelura 1.5% cream in 60-gram units. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is set to be completed by October 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,521.55, is for the supply of Opzelura 1.5% cream in 60 gram quantities. It is a firm fixed-price contract with a performance period through July 3, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00,...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9F81Delivery Order
AmerisourceBergen Drug Corp has been awarded a delivery order valued at $12,289.56 by the Defense Logistics Agency (DLA) for the supply of Opzelura 1.5% Cream in 60-gram quantities. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by November 17, 2025. The contract represents pharmaceutical support for federal medical procurement needs, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs and other federal health systems worldwide. AmerisourceBergen Drug Corp's portfolio of federal contracts demonstrates significant capability in fulfilling diverse pharmaceutical procurement requirements across multiple therapeutic domains for defense and federal civilian healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.3k | 11/14/25 |